MHRA

News

Could-artificial-intelligence-replace-pharma-reps

MHRA looks to AI to hunt for COVID-19 vaccine side effects

The UK drugs regulator has awarded a £1.5 million tender to a software company for an artificial intelligence tool that will be used to process “the expected high volume of COVID-19 vaccine

News

MHRA publishes guidance on medicine regulation after Brexit

The UK’s medicines regulator has published long-awaited guidance on regulation of medicines and medical devices as the UK approaches the end of its Brexit transition period at the end of th

News

UK patients get early access to Alnylam's ultra-rare disease...

The UK's regulator has granted early access to Alnylam's ultra-rare disease drug lumasiran, allowing patients with primary hyperoxaluria type 1 to gain access ahead of a regulatory decision

News

hydroxychloroquine sulphate tablets, in evaluation for treatment of COVID-19.Denmark, Mars 22, 2020

UK stops recruitment to hydroxychloroquine COVID-19 trials

The UK's drugs regulator has suspended recruitment to COVID-19 trials involving the drug hydroxychloroquine, saying that a review of study data did not provide evidence of any meaningful mo

News

UK okays early access to Gilead's remdesivir in seriously il...

The UK’s drugs regulator has said that there is enough evidence to support the use of Gilead’s COVID-19 drug remdesivir under its Early Access to Medicines Scheme (EAMS).

News

Large UK hospital to tear up paper records amid digitisation...

A hospital in the UK is preparing to scrap its old paper records and replace them with a new digital system that aims to improve efficiency.

MHRA looks to AI to hunt for COVID-19 vaccine side effects

MHRA publishes guidance on medicine regulation after Brexit

UK patients get early access to Alnylam's ultra-rare disease...

UK stops recruitment to hydroxychloroquine COVID-19 trials

UK okays early access to Gilead's remdesivir in seriously il...

Large UK hospital to tear up paper records amid digitisation...

Veraxa says delayed US listing is back on track

How to meet your physicians where they are online

MHRA

Editor's Picks